Page last updated: 2024-08-23

5,6-dihydroxy-2-methylaminotetralin and HIV Coinfection

5,6-dihydroxy-2-methylaminotetralin has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Crommentuyn, KM; Huitema, AD; Kuijpers, TW; Mathôt, RA; Scherpbier, HJ1

Other Studies

1 other study(ies) available for 5,6-dihydroxy-2-methylaminotetralin and HIV Coinfection

ArticleYear
Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Male; Nelfinavir; Netherlands; Risk Assessment; Severity of Illness Index; Tetrahydronaphthalenes; Treatment Outcome; Viral Load

2006